Reuters logo
J&J makes takeover approach for Swiss drugmaker Actelion -Bloomberg
2016年11月24日 / 晚上7点11分 / 10 个月前

J&J makes takeover approach for Swiss drugmaker Actelion -Bloomberg

Nov 24 (Reuters) - U.S. healthcare company Johnson & Johnson has approached Swiss biotechnology firm Actelion Ltd about a potential takeover, Bloomberg reported on Thursday, citing people it said were familiar with the matter.

The report said that deliberations are still at an early stage following Johnson & Johnson's initial offer, and Actelion is working with an adviser to explore options. (bloom.bg/2g8UTe3)

Actelion shares have risen more than 13 percent this year, valuing it at about $17 billion.

Johnson & Johnson and Actelion were not immediately available for comment. (Reporting by Ankit Ajmera in Bengaluru; Editing by Bill Rigby)

我们的标准汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below